All news

Pulse Biosciences stock hits all-time high of $58.94

Alpha Vantage · Investing.com UK · · AI-summarised by FinFlash

Pulse Biosciences (PLSE) hit an all-time high of $58.94, extending a 272.91% gain over the past year, after revenue rose 1,600% in the last twelve months. The company posted a wider-than-expected Q3 2026 loss of $0.32 per share on $395,000 in revenue, while Mizuho lifted its price target to $65 on early completion of a key study enrollment.

Read original source

PLSE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.